tiprankstipranks
Trending News
More News >
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market

Ajanta Pharma Limited (AJANTPHARM) Income Statement

Compare
4 Followers

Ajanta Pharma Limited Income Statement

Last quarter (Q1 2026), Ajanta Pharma Limited's total revenue was ₹13.03B, an increase of 13.78% from the same quarter last year. In Q1, Ajanta Pharma Limited's net income was ₹2.55B. See Ajanta Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 46.48B₹ 42.09B₹ 37.43B₹ 32.84B₹ 28.47B
Gross Profit
₹ 35.77B₹ 30.93B₹ 26.32B₹ 23.97B₹ 21.65B
Operating Expenses
₹ 13.14B₹ 11.20B₹ 19.11B₹ 7.02B₹ 5.17B
Depreciation and Amortization
₹ 1.44B₹ 1.35B₹ 1.30B₹ 1.25B₹ 1.16B
EBITDA
₹ 12.68B₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B
Operating Income
₹ 22.64B₹ 19.68B₹ 7.11B₹ 7.82B₹ 8.64B
Other Income/Expenses
₹ -10.74B₹ -8.54B₹ 341.80M₹ 1.28B₹ 364.60M
Pretax Income
₹ 11.89B₹ 11.14B₹ 7.45B₹ 9.09B₹ 9.00B
Net Income
₹ 9.20B₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B
Per Share Metrics
Basic EPS
₹ 73.56₹ 64.82₹ 45.89₹ 54.97₹ 50.06
Diluted EPS
₹ 73.53₹ 64.77₹ 45.89₹ 54.96₹ 50.06
Weighted Average Shares Outstanding
125.17M 125.92M 128.12M 129.66M 130.62M
Weighted Average Shares Outstanding (Diluted)
125.17M 126.01M 128.12M 129.66M 130.62M
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History